1. A phase I trial of the farnesyl transferase inhibitor SCH66336: Evidence for biological and clinical activity;Adjei;Cancer Res,2000
2. Genistein, a specific inhibitor of tyrosine-specific protein kinases;Akiyama;J Biol Chem,1987
3. Amrolia PJ, Reid SD, Gao L, et al: Allo-restricted cytotoxic T-cells specific for human CD45 show potent anti-leukemic activity. Blood (in press)
4. The heat shock protein 90 antagonist geldanamycin alters chaperone association with p210bcr-abl and v-src proteins before their degradation by the proteasome;An;Cell Growth Differ,2000
5. Tyrphostin-induced inhibition of p210bcr-abl tyrosine kinase activity induces K562 to differentiate;Anafi;Blood,1993